CBA Florida Inc. (fka CBAI)

[ttattletell]

"We believe all the necessary financial tools are in place to execute our three pillars of success in 2010: organic growth, acquisitions and diversification of revenue streams," said Mr. Schissler."
http://ih.advfn.com/p.php?pid=nmona&article=41051019

Organic Growth in 2010- None, CBAI needs to immediately raise $14M plus immediately increase the Authorized Shares count...

Acquisitions in 2010-

Stellacure has operated at a loss for the past several years, has negative working capital as of the acquisition date, and has a limited operating history, the Company determined that the fair value of any intangible assets identified as well as the non-controlling interest was $0. So 2011 will produce ? More start up costs!

Biocordcell Argentina S.A. was paid a purchase price of $525,000 or 51.1% of the outstanding shares
In 2011 If Bio net profits exceed $186,000 in 2010, the Company has agreed to pay an additional earn-out of $700,000 (and there is a scale)
So let’s look at this – They paid $525,000 and will give them an additional $700,000 to get 51.1% of $186,000 ..SO CBAI get’s $96,000 and pays out $700,000. 2011 projection loss of ($604,000)

On October 20, 2010, the Company filed as a co-proponent a proposed a Plan of Reorganization for Vivi under the United States Bankruptcy Code in exchange for the issuance of up to 64,488,889 shares of the Company’s common stock, and the Company’s agreement to make an additional senior secured loan in the amount of $300,000 to Vivi as working capital upon consummation of the Plan. A hearing on Confirmation of this proposed plan of reorganization is scheduled for the first quarter of 2011. That will be an additional outflow in 2011 of $300,000 for a bankrupt company.

10% of AXM Pharma

Diversification of Revenue Streams in 2010- When? Where?